Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT

Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT / Rocha, V., Labopin, M., Raiola, A.M., Devillier, R., Bramanti, S., Ciceri, F., Diez-Martin, J.L., Koc, Y., Tischer, J., Sica, S., Mohty, M., Gülbas, Z., Kulagin, A., Corral, L.L., Galimard, J.E., Sureda, A., Ruggeri, A., Rocha, V., Labopin, M., Raiola, A.M., et al.. - In: BONE MARROW TRANSPLANTATION. - ISSN 0268-3369. - 61:1(2026), pp. 75-81. [10.1038/s41409-025-02735-7]